Page 22 - index
P. 22


Fibrillazione Atriale in Medicina Generale



nd
non sono già in TAO, al fne di identifcare for- 13 Kastor JA. Atrial fbrillation. In: Arrhythmias. 2 ed.
mazioni trombotiche in atrio sinistro; Philadelphia: WB Saunders Co. 2000.
• prima di una procedura di ablazione transcate- 14 Ermini G. La fbrillazione atriale in Medicina Gene-
tere della FA (allo stesso scopo); rale. In: Filippi A, Battigelli D, D’Ambrosio G, et al.,
• quantifcare la velocità di fusso in auricola sini- eds. Malattie cardiovascolari in Medicina Generale.
stra e la presenza di ecocontrasto spontaneo Milano: Hippocrates Edizioni Medico Scientifche
(“smoke”), fattori predittivi importanti di au- 2012.
mentato rischio tromboembolico, per decidere 15 Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/
l’opportunità e l’intensità della terapia anticoa- ESC 2006 guidelines for the management of pa-
gulante. tients with atrial fbrillation: full text: a report of the
American College of Cardiology/American Heart
Bibliografa
Association Task Force on Practice Guidelines
1 Raviele A, Disertori M, Alboni P, et al. Linee guida and the European Society of Cardiology Commit-
AIAC 2010 per la gestione e il trattamento della f- tee for Practice Guidelines (Writing Committee to
brillazione atriale. GIAC 2010;13:61-157. Revise the 2001 guidelines for the management
2 Delise P. Le tachiaritmie sopraventricolari. Roma: of patients with atrial fbrillation) developed in col-
Casa Editrice Scientifca internazionale 1997. laboration with the European Heart Rhythm Asso-
3 The National Collaborating Centre for Chro- ciation and the Heart Rhythm Society. Circulation
nic Conditions. Atrial fbrillation. National clinical 2006;114:e257-354.
guideline for management in primary and se- 16 Kalus JS. Pharmacologic management of atrial f-
condary care. London: Royal College of Physi- brillation: established and emerging options. J Man-
cians 2006. http://www.nice.org.uk/nicemedia/ ag Care Pharm 2009;15(Suppl):S10-8.
live/10982/30055/30055.pdf. 17 Nattel S, Opie LH. Controversies in atrial fbrillation.
4 van Weert HC. Diagnosing atrial fbrillation in general Lancet 2006;367:262-72.
practice. BMJ 2007;335:355-6. 18 Opie LH, Gersh BJ. Drugs for the Heart. 7 ed. Phil-
th
5 Levy S, Camm AJ, Saksena S, et al. International adelphia: WB Saunders 2009.
consensus on nomenclature and classifcation of 19 Furlanello F, Stefenelli C. Schemi di terapia farma-
atrial fbrillation. Europace 2003;5:119-22. cologica antiaritmica. Roma: Casa Editrice Scientif-
6 Guidelines for the management of atrial fbrillation. ca Internazionale 1999.
The Task Force for the Management of Atrial Fibril- 20 Savelieva I, Camm JA. Anti-arrhythmic drug therapy
lation of the European Society of Cardiology (ESC). for atrial fbrillation: current anti-arrhythmic drugs,
Eur Heart J 2010;31:2369-429. investigational agents, and innovative approaches.
7 Meinertz T, Kirch W, Rosin L, et al. Management of Europace 2008;10:647-65.
atrial fbrillation by primary care physicians in Ger- 21 Camm JA, Camm CF, Savelieva I. Medical treat-
many: baseline results of the ATRIUM registry. Clin ment of atrial fbrillation. J Cardiovasc Med
Res Cardiol 2011;100:897-905. 2012;13:97-107.
8 Zoni Berisso M, Filippi A, Landolina M et al. 22 SIMG (Gruppo di lavoro: D’Ambrosio G, Filippi A,
Frequency, patient characteristics, treatment Musca G, Paduano R, Proto R, Tondo C, Violi F).
strategies and re source utilization of atrial f- La gestione del paziente con fbrillazione atriale in
brillation (from the Italian Survey of Atrial Fibril- Medicina Generale. www.simg.it/documenti/aree_
lation management [ISAF] study). Am J Cardiol cliniche/cardiovascolare/supporti/Paziente_fbrilla-
2013;111:705-11. zione.pdf.
9 Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial f- 23 Battigelli D. Palpitazioni. In: Filippi A, Battigelli D,
brillation management: a prospective survey in ESC D’Ambrosio G, et al., eds. Malattie cardiovascolari
member countries: the Euro Heart Survey on Atrial in Medicina Generale. Milano: Hippocrates Edizioni
Fibrillation. Eur Heart J 2005;26:2422-34. Medico Scientifche 2012.
10 Gillis AM, Verma A, Mario Talajic M, et al. Canadian 24 Camm AJ, Lip GY, De Caterina R, et al. 2012 fo-
Cardiovascular Society Atrial Fibrillation Guidelines cused update of the ESC Guidelines for the man-
2010: Rate and Rhythm Management. Can J Car- agement of atrial fbrillation: an update of the 2010
diol 2011;27:47-59. ESC Guidelines for the management of atrial fbrilla-
11 Healey JS, Connolly SJ, Gold MR. Subclinical Atrial tion. Developed with the special contribution of the
Fibrillation and the Risk of Stroke. N Engl J Med European Heart Rhythm Association. Eur Heart J
2012;366:120-9. 2012;33:2719-47.
12 Pandozi C, Calò I, Castro A, et al. Fibrillazione atriale. 25 Corrado G, Klein AL, Santarone M. Echocardio-
In: ANMCO. Trattato di cardiologia. Milano: Excerpta graphy in atrial fbrillation. J Cardiovasc Med (Hager-
Medica 2000. stown) 2006;7:498-504.

20
   17   18   19   20   21   22   23   24   25   26   27